Form 4: Tandem Diabetes Care Executive Elizabeth Gasser Reports Stock Transactions
SEC Form 4
EVP, Chief Strategy Officer of Tandem Diabetes Care, Elizabeth Gasser, reports acquisition and disposal of company stock and restricted stock units.
Summary
- Elizabeth Gasser, EVP, Chief Strategy Officer of Tandem Diabetes Care, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2025, Gasser acquired 1,147 shares of common stock through the Employee Stock Purchase Plan at $15.64 per share.
- She also acquired shares through the vesting of Restricted Stock Units (RSUs): 162, 474, 1,503 and 4,387 shares.
- Shares were withheld to cover tax obligations related to RSU vesting: 87, 254, 805 and 2,350 shares were withheld at a price of $22.7.
- Following these transactions, Gasser directly owns 11,200 shares and indirectly owns 11,749 shares through The Gasser Family Trust.
- The reported transactions include the vesting of RSUs awarded in 2021, 2022, 2023 and 2024 under the company's stock incentive plans.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing showing stock transactions by an executive. The ESPP purchase and RSU vesting are mildly positive, indicating confidence and performance, but the tax withholding is a neutral event.
Positives
- The reporting person acquired shares through the Employee Stock Purchase Plan, indicating confidence in the company's future.
- Vesting of RSUs suggests that the reporting person is meeting performance criteria.
Negatives
- Shares were withheld to cover tax obligations, which reduces the overall increase in direct ownership.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, reflecting insider activity.
Key Dates
| Date | Description |
|---|---|
| September 1, 2011 | Date of The Gasser Family Trust |
| May 18, 2021 | Date of RSU award pursuant to the 2013 Plan |
| May 25, 2022 | Date of RSU award pursuant to the 2013 Plan |
| May 15, 2023 | RSU vest date |
| May 25, 2023 | Date of RSU award pursuant to the 2023 Plan |
| May 23, 2024 | Date of RSU award pursuant to the 2023 Plan |
| November 18, 2024 | Start date of ESPP purchase period |
| May 15, 2025 | Date of earliest transaction, ESPP purchase period end date, and RSU vest date |
| May 19, 2025 | Date of signature |
Keywords
Form 4, beneficial ownership, Tandem Diabetes Care, stock transactions, Elizabeth Gasser, RSU, TNDM, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.